There’s one pharma-linked stock most investors have never heard of. It’s on Josh Brown’s list
- Posted on October 1, 2026
- By CNBC
- 2 Views
- 1 min read
In brief
Discover a lesser-known pharmaceutical infrastructure company that plays a critical role in vaccine distribution worldwide. Investment expert Josh Brown highlights this overlooked player in the healthcare supply chain sector. Learn why institutional investors are turning attention to logistics and distribution firms that enable global drug accessibility, representing untapped opportunities in the expanding pharmaceutical ecosystem beyond traditional drugmakers.
Summary auto-generated by AI from the original publisher's content. Editorial standards.
There’s one pharma-linked stock most investors have never heard of. It’s on Josh Brown’s list
If you've ever gotten a vaccine, this company was likely part of how that drug reached you, says Josh Brown.
